SARS-CoV-2 Infection in Pregnant Women and Their Newborns

There remain a number of uncertainties globally about the risks posed to women who are infected with SARS-CoV-2 during pregnancy. Furthermore, our understanding of the spread of COVID-19 in Sub-Saharan Africa is limited, owing to low testing rates in many parts of the continent. PeriCOVID Africa, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Etti, Melanie, Sekikubo, Musa, Nankabirwa, Victoria, Sommerfelt, Halvor, Freyne, Bridget, Kawaza, Kondwani, Gadama, Gladys, Jambo, Kondwani, Sevene, Esperança, Temmerman, Marleen, Magee, Laura A., von Dadelszen, Peter, Khalil, Asma, Doare, Kirsty Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2020
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546109/
https://www.ncbi.nlm.nih.gov/pubmed/33102152
http://dx.doi.org/10.5334/aogh.3072
Descripción
Sumario:There remain a number of uncertainties globally about the risks posed to women who are infected with SARS-CoV-2 during pregnancy. Furthermore, our understanding of the spread of COVID-19 in Sub-Saharan Africa is limited, owing to low testing rates in many parts of the continent. PeriCOVID Africa, in conjunction with the WHO/HRP Alliance, plans to address these knowledge gaps by harnessing research infrastructures in place in five sub-Saharan African countries in order to screen more than 50,000 pregnant women and their infants for SARS-CoV-2, while monitoring pregnancy and neonatal outcomes. We anticipate that the results of this study will provide much needed information about the risks that SARS-CoV-2 poses to pregnant women and their babies, as well as establishing potential routes of mother-to-child transmission.

Ejemplares similares